Pre-EDIT: A Randomized Feasibility Trial of Elastance-Directed Intrapleural Catheter or Talc Pleurodesis in Malignant Pleural Effusion.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
12 2019
Historique:
received: 16 04 2019
revised: 20 06 2019
accepted: 15 07 2019
pubmed: 3 8 2019
medline: 29 5 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Talc slurry pleurodesis (TSP) prevents recurrence of symptomatic malignant pleural effusion (MPE) in 71% to 78% patients. Nonexpansile lung (NEL) frequently accounts for TSP failure but is often occult predrainage, impairing selection of patients. NEL is associated with high pleural elastance (P Patients with symptomatic MPE were randomized 1:1 between EDIT and standard care (TSP). EDIT involved P Thirty-one patients were randomized (one allocation failure) over 12 months. P A phase 3 trial testing the effect of EDIT management on symptomatic MPE recurrence following TSP is feasible. ClinicalTrials.gov; No.: NCT03319186; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
Talc slurry pleurodesis (TSP) prevents recurrence of symptomatic malignant pleural effusion (MPE) in 71% to 78% patients. Nonexpansile lung (NEL) frequently accounts for TSP failure but is often occult predrainage, impairing selection of patients. NEL is associated with high pleural elastance (P
METHODS
Patients with symptomatic MPE were randomized 1:1 between EDIT and standard care (TSP). EDIT involved P
RESULTS
Thirty-one patients were randomized (one allocation failure) over 12 months. P
CONCLUSIONS
A phase 3 trial testing the effect of EDIT management on symptomatic MPE recurrence following TSP is feasible.
TRIAL REGISTRY
ClinicalTrials.gov; No.: NCT03319186; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 31374208
pii: S0012-3692(19)31384-4
doi: 10.1016/j.chest.2019.07.010
pii:
doi:

Substances chimiques

Talc 14807-96-6

Banques de données

ClinicalTrials.gov
['NCT03319186']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1204-1213

Informations de copyright

Copyright © 2019 American College of Chest Physicians. All rights reserved.

Auteurs

Geoffrey A Martin (GA)

Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Selina Tsim (S)

Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Andrew C Kidd (AC)

Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.

John E Foster (JE)

Glasgow Clinical Research Imaging Facility, Queen Elizabeth University Hospital, Glasgow, UK.

Philip McLoone (P)

Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Anthony Chalmers (A)

Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson West of Scotland Cancer Centre, Glasgow, UK.

Kevin G Blyth (KG)

Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH